These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7739846)

  • 1. Immunocytochemical localization of estrogen and progesterone receptors (ER & PgR) in breast cancer.
    Fukushima H; Matsuda M; Kawakami H; Kudo A; Kuroki Y; Sakurai M; Shohji T; Nagashima Y; Asami M; Hanaoka T
    Okajimas Folia Anat Jpn; 1995 Mar; 71(6):365-70. PubMed ID: 7739846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal receptor determination of 1,052 Chinese breast cancers.
    Chow LW; Ho P
    J Surg Oncol; 2000 Nov; 75(3):172-5. PubMed ID: 11088048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and methodological considerations in the quantification of estrogen and progesterone receptors using monoclonal antibodies in breast cancer].
    Navarro MA; Huguet J; Valero J; Samaniego JM; Rosel P; Sirvent JJ
    Med Clin (Barc); 1991 Jun; 97(2):41-4. PubMed ID: 1895780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inconsistency in quantitation of estrogen receptor and progesterone receptor with dextran charcoal method and enzyme immunoassay].
    Morimoto K; Hasuma T; Koh M; Ohtani S; Kinoshita H
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1597-605. PubMed ID: 12355945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival.
    Pertschuk LP; Kim DS; Nayer K; Feldman JG; Eisenberg KB; Carter AC; Rong ZT; Thelmo WL; Fleisher J; Greene GL
    Cancer; 1990 Oct; 66(8):1663-70. PubMed ID: 2208020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen & progesterone receptors measurement in breast cancer with enzyme-immunoassay & correlation with other prognostic factors.
    Redkar AA; Kabre SS; Mittra I
    Indian J Med Res; 1992 Feb; 96():1-8. PubMed ID: 1597324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer.
    Reiner A; Neumeister B; Spona J; Reiner G; Schemper M; Jakesz R
    Cancer Res; 1990 Nov; 50(21):7057-61. PubMed ID: 2208173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
    Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
    Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone-related factors associated with hormone receptor levels in breast cancer.
    Calzada L; Martinez JM; Sandoval T
    Gynecol Obstet Invest; 2001; 52(4):264-8. PubMed ID: 11729342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of serial semithin frozen sections to evaluate the co-localization of estrogen receptors and progesterone receptors in cells of breast cancer tissues.
    Kudo A; Fukushima H; Kawakami H; Matsuda M; Goya T; Hirano H
    J Histochem Cytochem; 1996 Jun; 44(6):615-20. PubMed ID: 8666746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.
    Effi AB; Aman NA; Koui BS; Koffi KD; Traoré ZC; Kouyate M
    BMC Cancer; 2017 Feb; 17(1):115. PubMed ID: 28173783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogen receptor negative-progesterone receptor positive phenotype in 1,211 breast tumours.
    Pichon MF; Milgrom E
    Br J Cancer; 1992 Jun; 65(6):895-7. PubMed ID: 1616860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
    Nishimukai A; Yagi T; Yanai A; Miyagawa Y; Enomoto Y; Murase K; Imamura M; Takatsuka Y; Sakita I; Hatada T; Miyoshi Y
    Clin Breast Cancer; 2015 Jun; 15(3):204-11. PubMed ID: 25600243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay.
    Cavaliere A; Bucciarelli E; Sidoni A; Bianchi G; Pietropaoli N; Ludovini V; Vitali R
    Cytometry; 1996 Sep; 26(3):204-8. PubMed ID: 8889392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on estrogen and progesterone receptors in human breast cancer by sucrose gradient centrifugation (author's transl)].
    Iino Y
    Nihon Naibunpi Gakkai Zasshi; 1979 Aug; 55(8):971-93. PubMed ID: 488478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infiltrating duct breast carcinoma: the role of estradiol and progesterone receptors].
    Salazar Esquivel EL; Morales Nájar R; Calzada Sánchez L
    Ginecol Obstet Mex; 1994 Mar; 62():85-90. PubMed ID: 8168725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor-negative progesterone receptor-positive breast cancer - "Nobody's land" or just an artifact?
    Kunc M; Biernat W; Senkus-Konefka E
    Cancer Treat Rev; 2018 Jun; 67():78-87. PubMed ID: 29772460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
    Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
    Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.
    Encarnación CA; Ciocca DR; McGuire WL; Clark GM; Fuqua SA; Osborne CK
    Breast Cancer Res Treat; 1993; 26(3):237-46. PubMed ID: 8251648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.